Gregory G. Enas - Concepedia

Author

Gregory G. Enas

Eli Lilly (United States)

Also Known As

G G Enas, G. G. Enas, GREGORY G. ENAS, Gregory Enas, Gregory G Enas, Gregory G. Enas

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Virginia Commonwealth University Medical Center

About

Gregory G. Enas is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	867
2	Health Sciences	2	2	618
3	Social Sciences	2	2	73
4	Engineering	1	1	70
5	Data Science	1	1	70

Gregory G. Enas

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Intracranial pressure: to monitor or not to monitor? Raj K. Narayan, P. R. S. Kishore, Donald P. Becker, Journal of neurosurgery HypertensionTraumatic Brain InjuryBrain LesionBlood PressureNeurovascular Disease	1982	590
Improved confidence of outcome prediction in severe head injury Raj K. Narayan, Richard P. Greenberg, J. D. Miller, Journal of neurosurgery	1981	536
Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations Ilya Lipkovich, Alex Dmitrienko, Jonathan Denne, Statistics in Medicine	2011	280
Fluoxetine: clinical pharmacology and physiologic disposition. Louis Lemberger, R. F. Bergstrom, Robert L. Wolen, PubMed Molecular PharmacologyTritiated Serotonin UptakeSerotonin UptakeHealthy SubjectsPharmacological Study	1985	196
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub). Louise R. Levine, Gregory G. Enas, W. Leigh Thompson, PubMed	1989	74
Choice of the smoothing parameter and efficiency of k-nearest neighbor classification Gregory G. Enas, Sung C. Choi Computers & Mathematics with Applications Data ClassificationInstance-based LearningClassification MethodImage AnalysisMachine Learning	1986	70
Clinical pharmacology of tomoxetine, a potential antidepressant. Robert L. Zerbe, Howard Rowe, Gregory G. Enas, Journal of Pharmacology and Experimental Therapeutics	1985	64
Effects of Therapeutic Pentobarbital Coma on Multimodality Evoked Potentials Recorded from Severely Head-injured Patients Pauline G. Newlon, Richard P. Greenberg, Gregory G. Enas, Neurosurgery	1983	64
The dynamics of neuronal dysfunction and recovery following severe head injury assessed with serial multimodality evoked potentials Pauline G. Newlon, Richard P. Greenberg, Marti S. Hyatt, Journal of neurosurgery	1982	58
Absence of a Relationship Between Adverse Events and Suicidality During Pharmacotherapy for Depression Gary D. Tollefson, Alvin H. Rampey, Charles M. Beasley, Journal of Clinical Psychopharmacology Adverse EventsPsychiatryMood SymptomPsychotropic MedicationSuicide	1994	53

Page 1